| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.22.4.617 |
| P8608 | Fatcat ID | release_jhcfe4behvbqrizddrbv3inmmu |
| P932 | PMC publication ID | 183802 |
| P698 | PubMed publication ID | 6295261 |
| P2093 | author name string | M Fujiu | |
| H Ishitsuka | |||
| Y Suhara | |||
| C Ohsawa | |||
| Y T Ninomiya | |||
| P2860 | cites work | Antipicornavirus flavone Ro 09-0179 | Q35718165 |
| Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity | Q39992220 | ||
| Properties of poliovirus propagated in medium containing cesium chloride: Implications for picornaviral structure | Q40186647 | ||
| Recovery of new viruses (coryzavirus) from cases of common cold in human adults. | Q43937510 | ||
| A physico-chemical sub-grouping of the mammalian picornaviruses | Q44477157 | ||
| Acid liability of rhinovirus type 14: effect of pH, time, and temperature | Q68669774 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 617-21 | |
| P577 | publication date | 1982-10-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410 | |
| P478 | volume | 22 |
| Q39816323 | 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating |
| Q28322324 | A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program |
| Q70189285 | A novel method for detecting the antiviral activity of flavans in their vapour phase |
| Q28377116 | Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives |
| Q39850940 | Antirhinovirus activity of purine nucleoside analogs |
| Q28360433 | Antirhinovirus compound 44,081 R.P. inhibits virus uncoating |
| Q30457345 | Antiviral chemotherapy and prophylaxis of viral respiratory disease |
| Q73563110 | Capsid and RNA stabilisation of the oral polio vaccine |
| Q93238473 | Chapter 12. Antiviral Agents |
| Q91901469 | Chapter 4 Picornavirus infections |
| Q30047670 | Chemotherapeutics |
| Q30451740 | Chemotherapy of rhinovirus colds |
| Q39849695 | Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime |
| Q40040756 | Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound. |
| Q41518340 | Epidemiology, pathogenesis, and treatment of the common cold |
| Q69840161 | In vitro activity of R 61837, a new antirhinovirus compound |
| Q28343180 | In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity |
| Q24647683 | Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles |
| Q30196063 | Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization |
| Q42200835 | Mechanism of action of the antiviral compound MDL 20,610. |
| Q38161573 | New antiviral compounds |
| Q35257419 | Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410. |
| Q37959377 | Perspectives in antiviral chemotherapy |
| Q40398238 | Picornavirus inhibitors |
| Q39879976 | Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. |
| Q34314501 | SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago). |
| Q35788236 | Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules |
| Q41779051 | Synthesis and anti-histaminic activity of some novel pyrimidines |
| Q37588593 | The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. |
| Q40041871 | Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation |
| Q30452190 | Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity |
Search more.